Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Parkinson's Disease

Free Subscription 06.10.2025 2 BMC Neurol 1 Exp Neurol 1 J Biol Chem 2 J Neural Transm (Vienna) 8 Mov Disord 2 Nat Rev Neurol 1 Neurobiol Dis 2 Neurology 1 Neuron 1 Neurosci Lett 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. IGUCHI T, Furuya T, Koinuma T, Nakajima A, et al
   Lymphomatosis cerebri presenting with rapidly progressive parkinsonism and Holmes tremor: a case report.
   BMC Neurol. 2025;25:392.
   PubMed         Abstract available
   
   
2. ZHENG H, Zhang D, Gan Y, Wu Y, et al
   Association between mitochondrial DNA copy number and the risk of Parkinson's disease: a meta-analysis and Mendelian randomization study.
   BMC Neurol. 2025;25:390.
   PubMed         Abstract available
   
   

   
   Exp Neurol

3. BERTASINI C, Rossini M, Grisotto J, Emerich D, et al
   Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonism.
   Exp Neurol. 2025;395:115474.
   PubMed         Abstract available
   
   

   
   J Biol Chem

4. YANG Q, Chen S, Zhang P, Lu Z, et al
   Negatively charged alpha-synuclein condensate modulates partitioning of molecules.
   J Biol Chem. 2025;301:110530.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

5. MIMORI M, Umehara T, Takatsu H, Okumura M, et al
   Reduced cerebrospinal fluid taurine is associated with nigrostriatal dopaminergic deficits in drug-naive Parkinson's disease.
   J Neural Transm (Vienna). 2025 Sep 29. doi: 10.1007/s00702-025-03027.
   PubMed         Abstract available
   
   
6. KIM R, Oh S, Woo KA, Shin CM, et al
   Blood microbiome signatures in the REM sleep behavior disorder-Lewy body disease continuum.
   J Neural Transm (Vienna). 2025;132:1143-1154.
   PubMed         Abstract available
   
   

   
   Mov Disord

7. WONG JK, Horn A, Middlebrooks EH, Burns MR, et al
   A Convergent Pathway for Stimulation-Induced Dyskinesia Following Deep Brain Stimulation.
   Mov Disord. 2025;40:1901-1907.
   PubMed         Abstract available
   
   
8. COHEN JS, Radhakrishnan H, Olm CA, Das SR, et al
   Microstructural Changes in the Tuberal Hypothalamus Correlate with Daytime Sleepiness in Lewy Body Disorders.
   Mov Disord. 2025;40:1919-1929.
   PubMed         Abstract available
   
   
9. ABDI-SARGEZEH B, Shirani S, Sharma A, Liu T, et al
   Prediction of Pathological Subthalamic Nucleus Beta Burst Occurrence in Parkinson's Disease.
   Mov Disord. 2025 Oct 3. doi: 10.1002/mds.70076.
   PubMed         Abstract available
   
   
10. SADABAD FE, Volpi T, Honhar P, Tinaz S, et al
    Measuring Dopamine Transporter Availability and Synaptic Density in Parkinson's Disease: A Dual-Tracer Positron Emission Tomography Imaging Study.
    Mov Disord. 2025 Oct 3. doi: 10.1002/mds.70041.
    PubMed         Abstract available
    
    
11. KISHORE A, Borgohain R, Puthenveedu DK, Rajan R, et al
    Reply to: "Early Indian Age at Onset of Parkinson's: A Case for a Gene-Environment Lens".
    Mov Disord. 2025 Sep 30. doi: 10.1002/mds.70053.
    PubMed        
    
    
12. ONDER H, Pekgoz Z, Oztekin MF
    Early Indian Age at Onset of Parkinson's: A Case for a Gene-Environment Lens.
    Mov Disord. 2025 Sep 30. doi: 10.1002/mds.70055.
    PubMed        
    
    
13. DE NEELING MGJ, Geraats S, Swinnen BEKS, Stam MJ, et al
    Temporal Dynamics of Beta Power Related to the Stun Effect in Parkinson's Disease Patients after Deep Brain Stimulation Surgery.
    Mov Disord. 2025 Sep 30. doi: 10.1002/mds.70042.
    PubMed         Abstract available
    
    
14. VARANDA S, Carneiro G, Pinho J
    Public Healthcare for People with Parkinson's Disease in Portugal: Rising to the Challenge.
    Mov Disord. 2025 Sep 29. doi: 10.1002/mds.70078.
    PubMed        
    
    

    
    Nat Rev Neurol

15. HORN A, Neumann WJ
    From adaptive deep brain stimulation to adaptive circuit targeting.
    Nat Rev Neurol. 2025;21:556-566.
    PubMed         Abstract available
    
    
16. FANNING S, Selkoe D
    Parkinson disease is a fatty acidopathy.
    Nat Rev Neurol. 2025 Oct 1. doi: 10.1038/s41582-025-01142.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

17. RODICHKIN AN, Brown AM, Devabathini P, McGlothan JL, et al
    Cerebellar dysfunction in a mouse model of childhood-onset manganese-induced dystonia parkinsonism.
    Neurobiol Dis. 2025;216:107115.
    PubMed         Abstract available
    
    

    
    Neurology

18. KRZYZANOWSKI B, Beyene KM, Turner JR, Racette BA, et al
    Ambient Trichloroethylene Exposure and Parkinson Disease Risk in Medicare Beneficiaries.
    Neurology. 2025;105:e214174.
    PubMed         Abstract available
    
    
19. DORSEY ER, Tanner CM
    Trichloroethylene and Parkinson Disease.
    Neurology. 2025;105:e214245.
    PubMed        
    
    

    
    Neuron

20. XIANG J, Tang J, Kang F, Ye J, et al
    Gut-induced alpha-Synuclein and Tau propagation initiate Parkinson's and Alzheimer's disease co-pathology and behavior impairments.
    Neuron. 2025;113:3300-3302.
    PubMed        
    
    

    
    Neurosci Lett

21. TOGAWA K, Matsumoto S, Deng L, Jin M, et al
    DOPAnization of alpha-synuclein exacerbates dopaminergic neurodegeneration in the substantia nigra.
    Neurosci Lett. 2025;865:138354.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

22. HAN M, Han Y, Jiang Z, Gao Y, et al
    Ultrasmall inorganic nanoparticles repair damaged meningeal lymphatic vessels to boost Parkinson's disease therapy.
    Proc Natl Acad Sci U S A. 2025;122:e2503434122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.